These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques. Kawada M; Igarashi H; Takeda A; Tsukamoto T; Yamamoto H; Dohki S; Takiguchi M; Matano T J Virol; 2006 Feb; 80(4):1949-58. PubMed ID: 16439550 [TBL] [Abstract][Full Text] [Related]
3. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520 [TBL] [Abstract][Full Text] [Related]
4. Use of molecular beacons for rapid, real-time, quantitative monitoring of cytotoxic T-lymphocyte epitope mutations in simian immunodeficiency virus. Peyerl FW; Barouch DH; Bazick HS; Manuel E; Letvin NL J Clin Microbiol; 2005 Sep; 43(9):4773-9. PubMed ID: 16145140 [TBL] [Abstract][Full Text] [Related]
5. Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts. Friedrich TC; McDermott AB; Reynolds MR; Piaskowski S; Fuenger S; De Souza IP; Rudersdorf R; Cullen C; Yant LJ; Vojnov L; Stephany J; Martin S; O'Connor DH; Wilson N; Watkins DI J Virol; 2004 Sep; 78(18):10064-73. PubMed ID: 15331739 [TBL] [Abstract][Full Text] [Related]
6. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Allen TM; O'Connor DH; Jing P; Dzuris JL; Mothé BR; Vogel TU; Dunphy E; Liebl ME; Emerson C; Wilson N; Kunstman KJ; Wang X; Allison DB; Hughes AL; Desrosiers RC; Altman JD; Wolinsky SM; Sette A; Watkins DI Nature; 2000 Sep; 407(6802):386-90. PubMed ID: 11014195 [TBL] [Abstract][Full Text] [Related]
7. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques. Loh L; Batten CJ; Petravic J; Davenport MP; Kent SJ J Virol; 2007 May; 81(10):5418-22. PubMed ID: 17344299 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. Chen ZW; Shen L; Miller MD; Ghim SH; Hughes AL; Letvin NL J Immunol; 1992 Dec; 149(12):4060-6. PubMed ID: 1460291 [TBL] [Abstract][Full Text] [Related]
9. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation. Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206 [TBL] [Abstract][Full Text] [Related]
10. Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques. Mason RD; De Rose R; Kent SJ Virology; 2009 Jun; 388(2):315-23. PubMed ID: 19394064 [TBL] [Abstract][Full Text] [Related]
11. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge. Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377 [TBL] [Abstract][Full Text] [Related]
12. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012 [TBL] [Abstract][Full Text] [Related]
13. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence? Vogel TU; Friedrich TC; O'Connor DH; Rehrauer W; Dodds EJ; Hickman H; Hildebrand W; Sidney J; Sette A; Hughes A; Horton H; Vielhuber K; Rudersdorf R; De Souza IP; Reynolds MR; Allen TM; Wilson N; Watkins DI J Virol; 2002 Nov; 76(22):11623-36. PubMed ID: 12388723 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746 [TBL] [Abstract][Full Text] [Related]
15. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. O'Connor DH; Allen TM; Vogel TU; Jing P; DeSouza IP; Dodds E; Dunphy EJ; Melsaether C; Mothé B; Yamamoto H; Horton H; Wilson N; Hughes AL; Watkins DI Nat Med; 2002 May; 8(5):493-9. PubMed ID: 11984594 [TBL] [Abstract][Full Text] [Related]
16. Correlation between viral RNA levels but not immune responses in plasma and tissues of macaques with long-standing SIVmac251 infection. Moniuszko M; Bogdan D; Pal R; Venzon D; Stevceva L; Nacsa J; Tryniszewska E; Edghill-Smith Y; Wolinsky SM; Franchini G Virology; 2005 Mar; 333(1):159-68. PubMed ID: 15708601 [TBL] [Abstract][Full Text] [Related]
17. Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection. Gooneratne SL; Alinejad-Rokny H; Ebrahimi D; Bohn PS; Wiseman RW; O'Connor DH; Davenport MP; Kent SJ J Virol; 2014 Dec; 88(24):14310-25. PubMed ID: 25275134 [TBL] [Abstract][Full Text] [Related]
18. Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques. Su J; Luscher MA; Xiong Y; Rustam T; Amara RR; Rakasz E; Robinson HL; MacDonald KS Int Immunol; 2005 May; 17(5):637-48. PubMed ID: 15824066 [TBL] [Abstract][Full Text] [Related]